Salvage radiation for a rising PSA following radical prostatectomy (Q44349532)

2 December 2017

title

Salvage radiation for a rising PSA following radical prostatectomy (English)

1 reference

2 December 2017

Jordan Maier

1

1 reference

2 December 2017

Jeffrey Forman

2

1 reference

2 December 2017

Samuel Tekyi-Mensah

3

1 reference

2 December 2017

Susan Bolton

4

1 reference

2 December 2017

Rajiv Patel

5

1 reference

2 December 2017

J Edson Pontes

6

1 reference

2 December 2017

publication date

1 January 2004

1 reference

2 December 2017

1 reference

2 December 2017

volume

22

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

50-56

1 reference

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

The role of radiotherapy after radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Natural history of progression after PSA elevation following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical Prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2003.12.001

10.1016/J.UROLONC.2003.12.001

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference